Commercialisation director joins Edinburgh BioQuarter
Life sciences entrepreneur Michael Capaldi joins Scotland\'s flagship project
Capaldi will lead a team of up to 15 people to progress a £12m commercialisation project that will bridge the gap between industry and research.
Capaldi has more than 26 years’ experience in the pharmaceutical and life sciences industries within the UK, Europe and the US.
You may also like
Research & Development
Weight loss drugs such as Ozempic may prevent stroke and reduce brain injury related complications
Three studies presented at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impacts of stroke and related brain injuries or reduce the risk of stroke altogether
Research & Development
Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
Qureight’s deep-learning image biomarkers and clinical data analytics platform used to analyse enrolled idiopathic pulmonary fibrosis (IPF) patient data, supporting efficacy outcome and expansion to larger global patient studies